Tauriga Sciences, Inc. (TAUG)

taug_logo_f_improf_179x131Many companies in the medical, wellness, and technology industries are expanding to the medical marijuana sector as it continues to show growth. Tauriga Sciences, Inc is one such company – it is a diversified biotechnology outfit that entered the marijuana space this year by acquiring a manufacturer of medical cannabis products.

Tauriga Sciences aims to build on its diversified portfolio by acquiring licenses, exclusive and non-exclusive rights, and entire businesses. Its featured subsidiaries are Microbial Robotics LLC (formerly Bacterial Robotics) and Pilus Energy LLC.

Microbial Robotics is a bio-engineering firm that ‘programs’ micro-organisms to produce microscopic robots. These can then be used in various applications such as reducing disease, cleaning water, growing foods, providing fuel, and producing therapeutics.

Meanwhile, Pilus Energy is a Tauriga-acquired subsidiary of Microbial Robotics. It uses genetically engineered bacteria that process wastewater to generate direct current electricity and produce useful gases and chemicals.

Founded in 2001, Tauriga Sciences formerly operated under various names such as New England Acquisitions, Inc, Atlantic Wine Agencies, Inc, and Novo Energies Corp. It changed to its current name in 2013.

Tauriga Sciences, Inc is now traded in the OTC markets as TAUG, with a market cap of USD 14.6 M. It is led by Dr. Stella Sung, Chairman, CEO, COO, and Interim CFO; Seth M. Shaw, VP for Strategic Planning; Dr. Lawrence A. May, Chief Medical Officer; and Ghalia Lahlou, Operations Manager. They are joined by Ian Harrison, VP and General Manager of Pilus Energy; and David Schweizer, VP of NuclearBot Development.


Yahoo! Finance: TAUG News

Latest Financial News for TAUG

Tauriga Sciences Inc. Proceeds with Fourth Production Run of Tauri-Gum Inventory to Support the Expansion of its Distribution Opportunities

New York, NY, April 12, 2019 -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the.

Tauriga Sciences Inc. Executes Distribution Agreement with Prolific South Florida Based Medical Practice Management Firm

New York, NY, April 10, 2019 -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the.

Tauriga Sciences, Inc. to Develop Airport Version of its CBD Infused Chewing Gum

NEW YORK, NY, April 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it is developing a special miniaturized Airport version of its CBD Infused chewing gum (branded as: Tauri-GumTM). The Company recently announced an increase in its Research & Development (“R & D”) budget, aimed at continually enhancing its Tauri-GumTM product line. Tauriga envisions this Airport version consisting of a miniaturized blister pack, containing three pieces of its CBD Infused gum (anticipated retail price of $6.99 per unit).

Tauriga Sciences Inc. Showcases its Graphic Design and Artwork for the Retail Display Boxes of its Two Newest Tauri-Gum Flavors: Blood Orange & Pomegranate

New York, NY, April 04, 2019 -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the.

Tauriga Sciences, Inc. Enters into Comprehensive Distribution Agreement to Establish its Tauri-Gum Brand in the New York City Metropolitan Area Market

NEW YORK, NY, April 01, 2019 -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the.